{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:50:32Z","timestamp":1789041032499,"version":"build-2803163510"},"reference-count":96,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejim.2015.07.013","type":"journal-article","created":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T14:47:00Z","timestamp":1437662820000},"page":"468-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Peripheral neuropathy: An underreported neurologic manifestation of inflammatory bowel disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Carmen","family":"Garc\u00eda-Cabo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Mor\u00eds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2015.07.013_bb0005","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMra1102942","article-title":"Ulcerative colitis","volume":"365","author":"Danese","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2015.07.013_bb0010","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.autrev.2014.01.029","article-title":"Diagnosis and classification of Crohn's disease","volume":"13","author":"Laass","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2015.07.013_bb0015","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2015.07.013_bb0020","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Crohn's disease","volume":"380","author":"Baumgart","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2015.07.013_bb0025","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(12)60150-0","article-title":"Ulcerative colitis","volume":"380","author":"Ordas","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2015.07.013_bb0030","first-page":"8764","article-title":"Neurological disorders and inflammatory bowel diseases","volume":"20","author":"Casella","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/B978-0-7020-4087-0.00040-1","article-title":"Neurologic manifestations of inflammatory bowel diseases","volume":"120","author":"Ferro","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0040","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3748\/wjg.v20.i5.1228","article-title":"Inflammatory bowel disease: an increased risk factor for neurologic complications","volume":"20","author":"Moris","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejim.2013.08.702","article-title":"Cerebral arterial infarction in inflammatory bowel diseases","volume":"25","author":"Katsanos","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2015.07.013_bb0050","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1468-1331.2010.03023.x","volume":"17","author":"Lauria","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0055","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMra1403718","article-title":"Cancers complicating inflammatory bowel disease","volume":"372","author":"Beaugerie","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2015.07.013_bb0060","first-page":"181","article-title":"Crohn disease and chronic inflammatory demyelinating polyneuropathy; a case report","volume":"50","author":"Boylu","year":"2010","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-7682-3-15","article-title":"Guillain\u2013Barre syndrome, tuberculosis and inflammatory bowel disease: a multiple association","volume":"3","author":"de la Torre","year":"2010","journal-title":"Int Arch Med"},{"key":"10.1016\/j.ejim.2015.07.013_bb0070","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ibd.21071","article-title":"Guillain\u2013Barre syndrome during a relapse of ulcerative colitis: a case report","volume":"16","author":"Krystallis","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2015.07.013_bb0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.medcli.2013.04.009","article-title":"Guillain\u2013Barre syndrome as extraintestinal manifestation during relapse of ulcerative colitis","volume":"142","author":"Rubio-Nazabal","year":"2014","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.ejim.2015.07.013_bb0080","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00384-009-0646-x","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy associated with inflammatory bowel diseases: questioning the autoimmunity hypothesis","volume":"24","author":"Ariatti","year":"2009","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ejim.2015.07.013_bb0085","doi-asserted-by":"crossref","first-page":"NP78","DOI":"10.1177\/0883073813503903","article-title":"Guillain\u2013Barre syndrome and Crohn disease: a case report","volume":"29","author":"Yanagida","year":"2014","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12883-015-0302-8","article-title":"Chronic inflammatory demyelinating polyneuropathy-like neuropathy as an initial presentation of Crohn's disease","volume":"15","author":"Kim","year":"2015","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0095","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1212\/WNL.37.8.1414","article-title":"Peripheral neuropathy associated with Crohn's disease","volume":"37","author":"Nemni","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2015.07.013_bb0100","first-page":"869","article-title":"Colonic Crohn's disease complicated with peripheral neuropathy","volume":"14","author":"Chaoui","year":"1990","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0248-8663(97)89299-5","article-title":"Sensorimotor polyneuropathy in a flare-up of Crohn disease","volume":"18","author":"Duval","year":"1997","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.ejim.2015.07.013_bb0110","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/pgmj.71.837.437","article-title":"Guillain\u2013Barre syndrome as an extraintestinal manifestation of Crohn's disease","volume":"71","author":"de la Fuente-Fernandez","year":"1995","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ejim.2015.07.013_bb0115","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/brain\/awh429","article-title":"Peripheral neuropathy in patients with inflammatory bowel disease","volume":"128","author":"Gondim","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.ejim.2015.07.013_bb0120","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1212\/WNL.0b013e3182904d16","article-title":"Peripheral neuropathy incidence in inflammatory bowel disease: a population-based study","volume":"80","author":"Figueroa","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2015.07.013_bb0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5114\/pjp.2012.32774","article-title":"Rare association of polyneuropathy and Crohn's disease: a clinicopathological study of 4 cases","volume":"63","author":"Kararizou","year":"2012","journal-title":"Pol J Pathol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/papr.12182","article-title":"Characterization of somatosensory profiles in patients with Crohn's disease","volume":"15","author":"Munster","year":"2015","journal-title":"Pain Pract"},{"key":"10.1016\/j.ejim.2015.07.013_bb0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/00365529108996495","article-title":"Disturbed autonomic nerve function in patients with Crohn's disease","volume":"26","author":"Lindgren","year":"1991","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0140","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3109\/00365529309096103","article-title":"Autonomic vagal nerve dysfunction in patients with ulcerative colitis","volume":"28","author":"Lindgren","year":"1993","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0145","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10620-008-0424-6","article-title":"Autonomic dysfunctions in patients with inflammatory bowel disease in clinical remission","volume":"54","author":"Sharma","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ejim.2015.07.013_bb0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-7-33","article-title":"Subclinical sympathetic neuropathy appears early in the course of Crohn's disease","volume":"7","author":"Ohlsson","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ibd.20304","article-title":"Peripheral neuropathy and neurological disorders in an unselected Brazilian population-based cohort of IBD patients","volume":"14","author":"Oliveira","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2015.07.013_bb0160","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1080\/00365520903199871","article-title":"Peripheral neuropathy in inflammatory bowel disease patients: a prospective cohort study","volume":"44","author":"Sassi","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0165","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5009\/gnl.2011.5.1.57","article-title":"The relationship between quiescent inflammatory bowel disease and peripheral polyneuropathy","volume":"5","author":"Cetinkaya","year":"2011","journal-title":"Gut Liver"},{"key":"10.1016\/j.ejim.2015.07.013_bb0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/CND.0b013e31821c55a1","article-title":"Peripheral neuropathic symptoms in celiac disease and inflammatory bowel disease","volume":"13","author":"Shen","year":"2012","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.ejim.2015.07.013_bb0175","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/MEG.0b013e32835ceca6","article-title":"Peripheral neuropathy electrophysiological screening in inflammatory bowel disease","volume":"25","author":"Babali","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0180","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1590\/0004-282X20140223","article-title":"A case\u2013control study of the prevalence of neurological diseases in inflammatory bowel disease (IBD)","volume":"73","author":"Gondim Fde","year":"2015","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.ejim.2015.07.013_bb0185","doi-asserted-by":"crossref","DOI":"10.1097\/MIB.0000000000000459","article-title":"Clinical and electrodiagnostic findings in patients with peripheral neuropathy and inflammatory bowel disease","author":"Gondim","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2015.07.013_bb0190","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1212\/WNL.45.3.416","article-title":"Neurologic aspects of inflammatory bowel disease","volume":"45","author":"Lossos","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2015.07.013_bb0195","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00007611-199706000-00005","article-title":"Neurologic and neuropsychiatric complications of Crohn's disease","volume":"90","author":"Elsehety","year":"1997","journal-title":"South Med J"},{"key":"10.1016\/j.ejim.2015.07.013_bb0200","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.gastro.2005.06.021","article-title":"The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study","volume":"129","author":"Bernstein","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2015.07.013_bb0205","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","article-title":"Guillain\u2013Barre syndrome: pathogenesis, diagnosis, treatment and prognosis","volume":"10","author":"van den Berg","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0210","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/j.lpm.2013.01.056","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy","volume":"42","author":"Van den Bergh","year":"2013","journal-title":"Presse Med"},{"key":"10.1016\/j.ejim.2015.07.013_bb0215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.autrev.2014.01.028","article-title":"Diagnosis and classification of ulcerative colitis","volume":"13","author":"Conrad","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2015.07.013_bb0220","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0016-5085(80)90155-9","article-title":"Healing of perineal Crohn's disease with metronidazole","volume":"79","author":"Bernstein","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2015.07.013_bb0225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/00365529109025034","article-title":"Neurophysiologic studies of patients with Crohn's disease on long-term treatment with metronidazole","volume":"26","author":"Stahlberg","year":"1991","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0230","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/106002809002400103","article-title":"Persistent metronidazole-induced peripheral neuropathy","volume":"24","author":"Boyce","year":"1990","journal-title":"DICP"},{"key":"10.1016\/j.ejim.2015.07.013_bb0235","first-page":"617","article-title":"Metrondazole-induced neurotoxicity","volume":"51","author":"Gupta","year":"2003","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.ejim.2015.07.013_bb0240","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.1.6164.663","article-title":"Drug-induced peripheral neuropathies","volume":"1","author":"Argov","year":"1979","journal-title":"Br Med J"},{"key":"10.1016\/j.ejim.2015.07.013_bb0245","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0016-5085(85)90137-4","article-title":"Peripheral neuropathy in Crohn's disease patients treated with metronidazole","volume":"88","author":"Duffy","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2015.07.013_bb0250","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1586\/1744666X.2015.1027687","article-title":"The clinical implications of thalidomide in inflammatory bowel diseases","volume":"11","author":"Diamanti","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0255","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.crohns.2014.04.005","article-title":"Consensus guidelines of ECCO\/ESPGHAN on the medical management of pediatric Crohn's disease","volume":"8","author":"Ruemmele","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.ejim.2015.07.013_bb0260","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2165\/00003495-200161060-00006","article-title":"Thalidomide in gastrointestinal disorders","volume":"61","author":"Bousvaros","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.ejim.2015.07.013_bb0265","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/apt.13181","article-title":"Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease","volume":"41","author":"Yang","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2015.07.013_bb0270","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00005176-200310000-00023","article-title":"Thalidomide in Crohn disease and the risk of peripheral neuropathy","volume":"37","author":"Ahmed","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ejim.2015.07.013_bb0275","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/apt.13057","article-title":"Long-term outcomes of thalidomide in refractory Crohn's disease","volume":"41","author":"Gerich","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2015.07.013_bb0280","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.2013.280777","article-title":"Effect of thalidomide on clinical remission in children and adolescents with refractory Crohn disease: a randomized clinical trial","volume":"310","author":"Lazzerini","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2015.07.013_bb0285","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MPG.0b013e318228349e","article-title":"Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab","volume":"54","author":"Felipez","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ejim.2015.07.013_bb0290","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nmd.2004.10.005","article-title":"Thalidomide neuropathy in childhood","volume":"15","author":"Fleming","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ejim.2015.07.013_bb0295","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2036.2006.03239.x","article-title":"Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies","volume":"25","author":"Plamondon","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2015.07.013_bb0300","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/gut.2003.029710","article-title":"Thalidomide for treatment of severe intestinal bleeding","volume":"53","author":"Bauditz","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2015.07.013_bb0305","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00004836-200208000-00006","article-title":"Thalidomide as \u201csalvage\u201d therapy for patients with delayed hypersensitivity response to infliximab: a case series","volume":"35","author":"Kane","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0310","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2036.2006.03211.x","article-title":"Efficacy and safety of thalidomide in children and young adults with intractable inflammatory bowel disease: long-term results","volume":"25","author":"Lazzerini","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2015.07.013_bb0315","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1046\/j.1365-2036.2002.01273.x","article-title":"An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease","volume":"16","author":"Sabate","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2015.07.013_bb0320","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00005176-200103000-00017","article-title":"Thalidomide-induced sensory neuropathy","volume":"32","author":"Strauss","year":"2001","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ejim.2015.07.013_bb0325","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0016-5085(99)70277-5","article-title":"An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease","volume":"117","author":"Vasiliauskas","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2015.07.013_bb0330","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1572-0241.2007.01718.x","article-title":"Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease","volume":"103","author":"Sternthal","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0335","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2015.07.013_bb0340","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/ar4582","article-title":"Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study","volume":"16","author":"Kaltsonoudis","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ejim.2015.07.013_bb0345","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1056\/NEJMct1209614","article-title":"Tumor necrosis factor inhibitors for inflammatory bowel disease","volume":"369","author":"Nielsen","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2015.07.013_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.03.004","article-title":"Tumor necrosis factor alpha (TNF-alpha), anti-TNF-alpha and demyelination revisited: an ongoing story","volume":"234","author":"Caminero","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0355","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","article-title":"Autoimmune diseases induced by biological agents: a double-edged sword?","volume":"9","author":"Ramos-Casals","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ejim.2015.07.013_bb0360","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/apt.12385","article-title":"Neurological events with tumour necrosis factor alpha inhibitors reported to the Food and Drug Administration Adverse Event Reporting System","volume":"38","author":"Deepak","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2015.07.013_bb0365","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/art.21814","article-title":"Guillain\u2013Barre and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy","volume":"54","author":"Shin","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2015.07.013_bb0370","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneurol.2009.11","article-title":"Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy","volume":"66","author":"Lozeron","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0375","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/mus.20924","article-title":"Tumor necrosis factor-alpha antagonists and neuropathy","volume":"37","author":"Stubgen","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejim.2015.07.013_bb0380","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/mus.21051","article-title":"Lewis\u2013Sumner syndrome associated with infliximab therapy in rheumatoid arthritis","volume":"38","author":"Hooper","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ejim.2015.07.013_bb0385","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/archneur.60.12.1755","article-title":"Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy","volume":"60","author":"Magda","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0390","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria","volume":"46","author":"Barohn","year":"1989","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0395","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2169\/internalmedicine.52.8452","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with Crohn's disease","volume":"52","author":"Ohyagi","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.ejim.2015.07.013_bb0400","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1085-9489.2005.00053.x","article-title":"Multifocal motor neuropathy during treatment with infliximab","volume":"10","author":"Cocito","year":"2005","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.ejim.2015.07.013_bb0405","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jns.2015.01.003","article-title":"Multifocal-motor-neuropathy-like disease associated with Infliximab treatment in a patient with Crohn's disease","volume":"349","author":"Fernandez-Menendez","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ejim.2015.07.013_bb0410","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1590\/S0004-282X2010000300022","article-title":"Motor neuropathy with multiple conduction blocks associated with TNF-alpha antagonist","volume":"68","author":"Carrilho","year":"2010","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.ejim.2015.07.013_bb0415","first-page":"1018","article-title":"Neurological complications of infliximab","volume":"33","author":"Jarand","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0420","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2010.01.004","article-title":"Acute motor and sensory axonal neuropathy and concomitant encephalopathy during tumor necrosis factor-alpha antagonist therapy","volume":"291","author":"Faivre","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ejim.2015.07.013_bb0425","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1002\/ibd.20870","article-title":"Peripheral neuropathy with infliximab therapy in inflammatory bowel disease","volume":"15","author":"Burger","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.ejim.2015.07.013_bb0430","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejim.2010.05.007","article-title":"Serum vitamin B12 and folate status in patients with inflammatory bowel diseases","volume":"21","author":"Yakut","year":"2010","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2015.07.013_bb0435","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jns.2009.07.030","article-title":"Rare sensory and autonomic disturbances associated with vitamin B12 deficiency","volume":"287","author":"Puntambekar","year":"2009","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.ejim.2015.07.013_bb0440","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/B978-0-7020-4087-0.00060-7","article-title":"Neurologic aspects of cobalamin (B12) deficiency","volume":"120","author":"Kumar","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0445","doi-asserted-by":"crossref","first-page":"608534","DOI":"10.1155\/2012\/608534","article-title":"The neurological complications of nutritional deficiency following bariatric surgery","volume":"2012","author":"Becker","year":"2012","journal-title":"J Obes"},{"key":"10.1016\/j.ejim.2015.07.013_bb0450","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.nut.2008.02.022","article-title":"Rapidly developing weakness mimicking Guillain\u2013Barre syndrome in beriberi neuropathy: two case reports","volume":"24","author":"Koike","year":"2008","journal-title":"Nutrition"},{"key":"10.1016\/j.ejim.2015.07.013_bb0455","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00004836-199108000-00015","article-title":"Peripheral neuropathy and folate deficiency as the first sign of Crohn's disease","volume":"13","author":"Lossos","year":"1991","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2015.07.013_bb0460","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1212\/WNL.0000000000001343","article-title":"Clinicopathologic features of folate-deficiency neuropathy","volume":"84","author":"Koike","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2015.07.013_bb0465","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ncl.2009.09.006","article-title":"Neurologic presentations of nutritional deficiencies","volume":"28","author":"Kumar","year":"2010","journal-title":"Neurol Clin"},{"key":"10.1016\/j.ejim.2015.07.013_bb0470","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00005176-199802000-00002","article-title":"Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity","volume":"26","author":"Bousvaros","year":"1998","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ejim.2015.07.013_bb0475","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4103\/0028-3886.141219","article-title":"A new differential diagnosis for acquired demyelinating neuropathy: copper deficiency","volume":"62","author":"Karlikaya","year":"2014","journal-title":"Neurol India"},{"key":"10.1016\/j.ejim.2015.07.013_bb0480","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12354","article-title":"Impact of copper deficiency in humans","volume":"1314","author":"Prohaska","year":"2014","journal-title":"Ann N Y Acad Sci"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515002393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620515002393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T16:55:21Z","timestamp":1567011321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620515002393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":96,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0953620515002393"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2015.07.013","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral neuropathy: An underreported neurologic manifestation of inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2015.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}